Abstract
Tanshinone IIA is the major active ingredient of Salviae miltiorrhizae extract, and has been widely used in China for the treatment of cardiovascular and cerebrovascular diseases. We have identified proteins modulated by Tanshinone IIA during the formation of macrophage-derived foam cells to uncover its anti-atherosclerotic mechanism. Low density lipoprotein (LDL) isolated from hyperlipidemia patients, designated as HP-LDL. HP-LDL (80 μg/mL for 24 h) can improve the total cholesterol and the proportion of cholesterol ester in the RAW264.7 macrophage and transform it into foam cell, which can be inhibited by Tanshinone IIA (20 μg/mL, 24 h). Two-dimensional electrophoresis and matrixassisted laser desorption ionization time-of-flight mass spectrometry were used to analysis and identify the proteins differentially expressed after Tanshinone IIA treatment of HP-LDL induced RAW264.7 macrophage transformation into foam cell. Fifteen proteins have been identified, which involved the different cellular functions, such as regulation of cytosolic calcium concentration, oxidative stress, inflammation, cell proliferation and differentiation, and lipid metabolism. This provides new insight into the anti-atherosclerotic mechanism of Tanshinone IIA.
Keywords: Foam cell, LDL, proteome, RAW264.7, tanshinone IIA.
Graphical Abstract
Related Journals
Related Books
Industrial Applications of Soil Microbes
Industrial Applications of Soil Microbes
Algal Biotechnology for Fuel Applications
Biopolymers Towards Green and Sustainable Development
Terpenoids: Recent Advances in Extraction, Biochemistry and Biotechnology
Environmental Microbiology: Advanced Research and Multidisciplinary Applications
Biomarkers in Medicine
Industrial Applications of Soil Microbes
Recent Advances in Biotechnology
Sustainable Utilization of Fungi in Agriculture and Industry
23